BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 2, 2013
View Archived Issues
Biomarker analysis and mental fitness testing for driving aptitude in patients with cirrhosis
Read More
Gilead Sciences reviews events of second quarter 2013
Read More
Targeting Abeta oligomers for the treatment of Alzheimer's disease
Read More
Bayer discloses novel sGC activators for cardiovascular disorders
Read More
Baltic Bio synthesizes new AMPK activators for diabetes
Read More
Cellmid collaborates on marker for colorectal cancer diagnosis
Read More
Preclinical and clinical evaluation of a snake venom polypeptide as an antithrombotic
Read More
Ex vivo evaluation of a bispecific antibody for the treatment of patients with hemophilia A
Read More
Phase II study of SHACT meets efficacy and safety endpoints
Read More
Signature Therapeutics receives award to advance abuse-deterrent oxycodone
Read More
Nektar Therapeutics completes enrollment in phase III BEACON study
Read More
ReGenX Biosciences and Audentes Therapeutics to develop NAV vector treatments
Read More
Summit awarded grant to develop DMD therapy
Read More
Spanish researchers discover biomarker for Lewy body dementia diagnosis
Read More
Omeros submits NDA to the FDA for OMS-302
Read More
IntelligentMDx receives FDA clearance for vancomycin-resistant enterococci assay
Read More
BioDelivery Sciences submits NDA to FDA for Bunavail
Read More
PrEP trial to evaluate prevention using antiretroviral drugs in HIV-negative individuals
Read More
S1 Biopharma initiates phase IIa trial of Lorexys in premenopausal women with HSDD
Read More
New company AveXis to focus on new technology for disease treatment
Read More
OncoTherapy Science identifies potent drug candidates for a novel kinase target
Read More
Cubist Pharmaceuticals signs agreements to acquire two companies
Read More
OncoTherapy's phase III trial of peptide cocktail vaccine for pancreatic cancer remains on schedule
Read More
MolecularMD obtains license for cancer diagnosis technology
Read More
Takeda receives marketing authorization in China for Nesina
Read More
